Eplerenone in the treatment of Gitelman's syndrome

Internal Medicine Journal

Volumn 38, Issue 5, 2008, Pages 377-

  Morton, A ^a  

^a MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; EPLERENONE; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; SODIUM CHLORIDE COTRANSPORTER; SPIRONOLACTONE;

ADULT; ALLELE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; DNA SEQUENCE; FEMALE; GENE MUTATION; GITELMAN SYNDROME; GYNECOMASTIA; HUMAN; HYPOKALEMIA; IMPOTENCE; LETHARGY; LETTER; MAGNESIUM BLOOD LEVEL; MENSTRUAL IRREGULARITY; PHYSICAL EXAMINATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; FEMALE; GITELMAN SYNDROME; HUMANS; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 42049103712     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01664.x     Document Type: Letter

References (4)

1. Colussi G, Rombola G, De Ferrari ME, Macaluso M, Minetti L. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. Am J Nephrol 1994 14 : 127 35.
2. Weinberger MH, Roniker B, Krause SL, Weiss RJ. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 2002 15 : 709 16.
3. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003 348 : 1309 21.
4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999 341 : 709 17.